ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JANUARY 2026
ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JANUARY 2026 |
| [04-February-2026] |
GOTHENBURG, Sweden , Feb. 4, 2026 /PRNewswire/ -- Zinzino group revenue increased with a total of 20 %, compared with the previous year. The revenue in January for Zinzino's sales markets increased by 20% and amounted to SEK 274.1 (229.2) million. Faun Pharma's external sales increased and amounted to SEK 7.1 (4.7) million. Overall, the Group increased revenues by 20 % to SEK 281.2 (233.9) million compared with the previous year. Revenues were distributed as follows:
Countries in regions: -The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden -Central Europe: Austria, Germany, Switzerland -East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania -South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands -The Baltics: Estonia, Latvia, Lithuania -North America: Canada, USA, Mexico -South America: Peru, Colombia -Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea -Africa: South Africa For more information: Pictures for publication free of charge : marketing@zinzino.com Certified Adviser: Tapper Partners AB This information was brought to you by Cision http://news.cision.com https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-january-2026,c4302364 The following files are available for download:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Codes: ISIN:SE0002480442,OTC-BB:ZNZNF,OTC-PINK:ZNZNF,Stockholm:ZZB |
View original content:
